Single-Port robot takes on complex belly surgeries

NCT ID NCT06562179

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing a new robotic system that uses just one small incision to perform surgeries on the liver, pancreas, stomach, and esophagus. The goal is to see if this single-port approach is safe and works well for these complex operations. The study will enroll 35 adults with either benign or malignant conditions who need these surgeries.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
da Vinci SP® Single-Port Robotic Surgical System (device)
What this could lead to
If successful, this could show that single-port robotic surgery is a safe and effective option for complex abdominal surgeries, potentially leading to less pain and faster recovery.
What could go wrong
This is a small, early-stage study with only 35 participants, so results may not apply to everyone. The surgery is complex and carries risks like infection, bleeding, or need to switch to a different surgical approach.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BENIGN GALLBLADDER DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • AdventhHealth

    RECRUITING

    Tampa, Florida, 33613, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.